These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 14680836

  • 1. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth.
    He GA, Luo JX, Zhang TY, Wang FY, Li RF.
    Biochem Biophys Res Commun; 2003 Dec 19; 312(3):801-5. PubMed ID: 14680836
    [Abstract] [Full Text] [Related]

  • 2. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA, Luo JX, Zhang TY, Hu ZS, Wang FY.
    Biochem Biophys Res Commun; 2004 May 28; 318(2):354-60. PubMed ID: 15120609
    [Abstract] [Full Text] [Related]

  • 3. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM, Zhang YM, Fu SB, Liu XH, Fu X, Yu Y, Zhang ZY.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2324-30. PubMed ID: 19080341
    [Abstract] [Full Text] [Related]

  • 4. Recombinant non-collagenous domain of alpha2(IV) collagen causes involution of choroidal neovascularization by inducing apoptosis.
    Lima E Silva R, Kachi S, Akiyama H, Shen J, Aslam S, Yuan Gong Y, Khu NH, Hatara MC, Boutaud A, Peterson R, Campochiaro PA.
    J Cell Physiol; 2006 Jul 20; 208(1):161-6. PubMed ID: 16557520
    [Abstract] [Full Text] [Related]

  • 5. Enhancement of antiangiogenic effects of human canstatin with a hypoxia-regulated transgene vector in lung cancer model.
    Li YY, Qian GS, Huang GJ, Chen F, Qian P, Yu SC, Wang CZ, Li Q, Wang JC, Wu GM.
    Cancer J; 2006 Jul 20; 12(2):136-46. PubMed ID: 16630405
    [Abstract] [Full Text] [Related]

  • 6. Recombinant mouse canstatin inhibits chicken embryo chorioallantoic membrane angiogenesis and endothelial cell proliferation.
    Hou WH, Wang TY, Yuan BM, Chai YR, Jia YL, Tian F, Wang JM, Xue LX.
    Acta Biochim Biophys Sin (Shanghai); 2004 Dec 20; 36(12):845-50. PubMed ID: 15592653
    [Abstract] [Full Text] [Related]

  • 7. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M, Zilberberg L, Wilting J, Canron X, Carrabba G, Giussani C, Pluderi M, Bello L, Bikfalvi A.
    Cancer Res; 2002 Dec 01; 62(23):6884-90. PubMed ID: 12460903
    [Abstract] [Full Text] [Related]

  • 8. Expression, purification, and bioactivity of human tumstatin from Escherichia coli.
    Gu Q, Zhang T, Luo J, Wang F.
    Protein Expr Purif; 2006 Jun 01; 47(2):461-6. PubMed ID: 16503164
    [Abstract] [Full Text] [Related]

  • 9. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L, Donnini S, Chillemi F, Giachetti A, Ziche M.
    Clin Cancer Res; 2003 Nov 01; 9(14):5358-69. PubMed ID: 14614021
    [Abstract] [Full Text] [Related]

  • 10. N-/C-terminal deleted mutant of human endostatin efficiently acts as an anti-angiogenic and anti-tumorigenic agent.
    Cho H, Kim WJ, Lee YM, Kim YM, Kwon YG, Park YS, Choi EY, Kim KW.
    Oncol Rep; 2004 Jan 01; 11(1):191-5. PubMed ID: 14654925
    [Abstract] [Full Text] [Related]

  • 11. NC1 domain of human type VIII collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis.
    Xu R, Yao ZY, Xin L, Zhang Q, Li TP, Gan RB.
    Biochem Biophys Res Commun; 2001 Nov 23; 289(1):264-8. PubMed ID: 11708810
    [Abstract] [Full Text] [Related]

  • 12. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
    Hwang-Bo J, Yoo KH, Park JH, Jeong HS, Chung IS.
    Int J Cancer; 2012 Jul 15; 131(2):298-309. PubMed ID: 21823121
    [Abstract] [Full Text] [Related]

  • 13. Thrombospondin-1 type 1 repeat recombinant proteins inhibit tumor growth through transforming growth factor-beta-dependent and -independent mechanisms.
    Miao WM, Seng WL, Duquette M, Lawler P, Laus C, Lawler J.
    Cancer Res; 2001 Nov 01; 61(21):7830-9. PubMed ID: 11691800
    [Abstract] [Full Text] [Related]

  • 14. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth.
    Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R.
    J Biol Chem; 2000 Jan 14; 275(2):1209-15. PubMed ID: 10625665
    [Abstract] [Full Text] [Related]

  • 15. Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesis.
    Berger AC, Alexander HR, Tang G, Wu PS, Hewitt SM, Turner E, Kruger E, Figg WD, Grove A, Kohn E, Stern D, Libutti SK.
    Microvasc Res; 2000 Jul 14; 60(1):70-80. PubMed ID: 10873516
    [Abstract] [Full Text] [Related]

  • 16. Anti-angiogenic cues from vascular basement membrane collagen.
    Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, Volk R, Zamborsky ED, Herman S, Sarkar PK, Ericksen MB, Dhanabal M, Simons M, Post M, Kufe DW, Weichselbaum RR, Sukhatme VP, Kalluri R.
    Cancer Res; 2000 May 01; 60(9):2520-6. PubMed ID: 10811134
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE.
    Oncogene; 2005 Jan 27; 24(5):790-800. PubMed ID: 15592523
    [Abstract] [Full Text] [Related]

  • 18. Hypoestoxide, a natural nonmutagenic diterpenoid with antiangiogenic and antitumor activity: possible mechanisms of action.
    Ojo-Amaize EA, Nchekwube EJ, Cottam HB, Bai R, Verdier-Pinard P, Kakkanaiah VN, Varner JA, Leoni L, Okogun JI, Adesomoju AA, Oyemade OA, Hamel E.
    Cancer Res; 2002 Jul 15; 62(14):4007-14. PubMed ID: 12124334
    [Abstract] [Full Text] [Related]

  • 19. A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin.
    Xiao F, Wei Y, Yang L, Zhao X, Tian L, Ding Z, Yuan S, Lou Y, Liu F, Wen Y, Li J, Deng H, Kang B, Mao Y, Lei S, He Q, Su J, Lu Y, Niu T, Hou J, Huang MJ.
    Gene Ther; 2002 Sep 15; 9(18):1207-13. PubMed ID: 12215887
    [Abstract] [Full Text] [Related]

  • 20. The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growth.
    Akakura N, Hoogland C, Takada YK, Saegusa J, Ye X, Liu FT, Cheung AT, Takada Y.
    Cancer Res; 2006 Oct 01; 66(19):9691-7. PubMed ID: 17018627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.